Institutional members access full text with Ovid®

Breast Cancer Screening: Clinical, Radiologic, and Biochemical

FELDMAN, ELIZABETH D. MD, FACS; OPPONG, BRIDGET A. MD; WILLEY, SHAWNA C. MD, FACS

Clinical Obstetrics & Gynecology: September 2012 - Volume 55 - Issue 3 - p 662–670
doi: 10.1097/GRF.0b013e31825ca884
Office Gynecology

Breast cancer screening is a highly complex and more recently a controversial topic. Conventional screening includes breast self-examination, clinical breast examination, and screening mammography. Several newer imaging modalities have been introduced into the screening armamentarium including breast magnetic resonance imaging and whole-breast automated ultrasound. Novel imaging techniques like positron emission mammography are currently under clinical investigation in the hopes of improving the sensitivity of breast cancer screening. In addition, the development of biochemical assays, which employ minimally invasive sampling are also promising.

Division of Surgical Oncology, Georgetown University Hospital, Washington, District of Columbia

The authors declare that they have nothing to disclose.

Correspondence: Shawna C. Willey, MD, FACS, Betty Lou Ourisman Breast Health Center, Division of Surgical Oncology, Georgetown University Hospital, Washington, DC. E-mail: scw9@gunet.georgetown.edu

© 2012 Lippincott Williams & Wilkins, Inc.